category

Earnings Report

Shake Shack Results Beat Estimates, Raises Forecast

Shake Shack, known for its juicy antibiotic-free hamburgers and frozen custard shakes, on Thursday reported results that topped expectations and raised its same-restaurant sales forecast for the year.

Nordstrom Shares Slammed After Earnings

The department store operator reported a drop in first-quarter sales at established stores and slashed profit expectations for the year, adding to the gloom in the department store sector.

Disney Is Not Down And Out, Despite Stock Slide

Walt Disney (NYSE:DIS) stock fell more than four points in early trading Wednesday after struggles in the cable networks segment caused the company to miss Wall Street’s sky-high estimates for its second quarter earnings.

Wendy's Raises Forecast, Profit Beats Estimates

Burger chain Wendy's raised its full-year profit forecast and reported a higher-than-expected quarterly profit, as new promotions such as its '4 for $4 meal' and renovated restaurants attracted more diners.

Zootopia Powers Disney Revenue

Walt Disney Co's (NYSE:DIS) reported a 4.1 percent rise in quarterly revenue, helped by the box-office success of "Star Wars: The Force Awakens" and animated movie "Zootopia".

Lumber Liquidators Sales Fall Again, Miss Estimates

Lumber Liquidators' sales fell for the fourth straight quarter, missing analysts' expectations again, as the hardwood flooring retailer struggles to revive demand amid fears that some of its products could cause cancer.

Cigna Reports Better-Than-Expected 1Q Profit

U.S. health insurer Cigna, which is being bought by larger rival Anthem Inc, reported a better-than-expected quarterly profit as more customers signed up for its Medicare Advantage business, boosting premiums.

News Corp's Profit Hit By Charge

News Corp, the owner of the Wall Street Journal and book publisher HarperCollins, reported its fifth drop in quarterly revenue in a row as print ad sales decline.

Merck 1Q Profit Beats, Raises Forecast

Dow component Merck reported an adjusted 1Q profit of $0.89 per share, topping the estimate for $0.85. Revenue for the drugmaker came in at $9.3 billion, falling short of the estimate for $9.46 billion.